Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'u-PA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 107 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Baker, JKL; Elshaw, SR; Mathewman, GEL; Nichols, CE; Murray, AK; Parsons, MA; Rennie, IG; Sisley, K
      Expression of integrins, degradative enzymes and their inhibitors in uvealmelanoma: differences between in vitro and in vivo expression

      MELANOMA RESEARCH
    2. Fredstorp-Lidebring, M; Bendahl, PO; Brunner, N; Casslen, B; Hogberg, T; Langstrom-Einarsson, E; Willen, R; Ferno, M
      Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer

      EUROPEAN JOURNAL OF CANCER
    3. Magnusson, C; Hogklint, L; Libelius, R; Tagerud, S
      Expression of mRNA for plasminogen activators and protease nexin-1 in innervated and denervated mouse skeletal muscle

      JOURNAL OF NEUROSCIENCE RESEARCH
    4. Ichiki, K; Mitani, N; Doki, Y; Hara, H; Misaki, T; Saiki, I
      Regulation of activator protein-1 activity in the mediastinal lymph node metastasis of lung cancer

      CLINICAL & EXPERIMENTAL METASTASIS
    5. Shetty, S; Idell, S
      Urokinase induces expression of its own receptor in Beas2B lung epithelialcells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    6. Pietruszka, AJ; Rubin, KH; Garcia, MO
      Ra-226-Th-230-U-238 disequilibria of historical Kilauea lavas (1790-1982) and the dynamics of mantle melting within the Hawaiian plume

      EARTH AND PLANETARY SCIENCE LETTERS
    7. Moir, E; Booth, NA; Bennett, B; Robbie, LA
      Polymorphonuclear leucocytes mediate endogenous thrombus lysis via a u-PA-dependent mechanism

      BRITISH JOURNAL OF HAEMATOLOGY
    8. Kahr, WHA; Zheng, SL; Sheth, PM; Pai, M; Cowie, A; Bouchard, M; Podor, TJ; Rivard, GE; Hayward, CPM
      Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator

      BLOOD
    9. Muneer, E; Bell, J; Doctor, VM
      Mechanism of enhancement by fucoidan and CNBr-fibrinogen digest of the activation of glu-plasminogen by tissue plasminogen activator

      EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS
    10. Pap, G; Eberhardt, R; Rocken, C; Nebelung, W; Neumann, HW; Roessner, A
      Expression of stromelysin and urokinase type plasminogen activator proteinin resection specimens and biopsies at different stages of osteoarthritis of the knee

      PATHOLOGY RESEARCH AND PRACTICE
    11. Gunther, A; Mosavi, P; Ruppert, C; Heinemann, S; Temmesfeld, B; Velcovsky, HG; Morr, H; Grimminger, F; Walmrath, D; Seeger, W
      Enhanced tissue factor pathway activity and fibrin turnover in the alveolar compartment of patients with interstitial lung disease

      THROMBOSIS AND HAEMOSTASIS
    12. Fukao, H; Matsuo, O
      Antithrombotic regulation in human endothelial cells by fibrinolytic factors

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    13. Huang, GW; Sunagawa, M; Li, JE; Shimada, S; Gang, Z; Tokeshi, Y; Kosugi, T
      The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma

      LARYNGOSCOPE
    14. Lijnen, HR; Arza, B; Van Hoef, B; Collen, D; Declerck, PJ
      Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3)

      JOURNAL OF BIOLOGICAL CHEMISTRY
    15. Podor, TJ; Peterson, CB; Lawrence, DA; Stefansson, S; Shaughnessy, SG; Foulon, DM; Butcher, M; Weitz, JI
      Type 1 plasminogen activator inhibitor binds to fibrin via vitronectin

      JOURNAL OF BIOLOGICAL CHEMISTRY
    16. Zou, HB; Zindler, A
      Theoretical studies of U-238-Th-230-Ra-226 and U-235-Pa-231 disequilibria in young lavas produced by mantle melting

      GEOCHIMICA ET COSMOCHIMICA ACTA
    17. Chazaud, B; Bonavaud, S; Plonquet, A; Pouchelet, M; Gherardi, RK; Barlovatz-Meimon, G
      Involvement of the [uPAR : uPA : PAI-1 : LRP] complex in human myogenic cell motility

      EXPERIMENTAL CELL RESEARCH
    18. Fukao, H; Ikeda, M; Ichikawa, T; Inufusa, H; Okada, K; Ueshima, S; Matsuo, O
      Effect of hyperthermia on the viability and the fibrinolytic potential of human cancer cell lines

      CLINICA CHIMICA ACTA
    19. Condomines, M; Sigmarsson, O
      U-238-Th-230 disequilibria and mantle melting processes: a discussion

      CHEMICAL GEOLOGY
    20. Kitange, G; Tsunoda, K; Anda, T; Nakamura, S; Yasunaga, A; Naito, S; Shibata, S
      Immunohistochemical expression of Ets-1 transcription factor and the urokinase-type plasminogen activator is correlated with the malignant and invasive potential in meningiomas

      CANCER
    21. Robbie, L; Berry, S; Moir, E; Booth, NA; Culligan, D; Tighe, J; Watson, H; King, D; Bennett, B
      Myeloid leukaemic cells can lyse fibrin directly

      BRITISH JOURNAL OF HAEMATOLOGY
    22. Robbie, LA; Dummer, S; Booth, NA; Adey, GD; Bennett, B
      Plasminogen activator inhibitor 2 and urokinase-type plasminogen activatorin plasma and leucocytes in patients with severe sepsis

      BRITISH JOURNAL OF HAEMATOLOGY
    23. Zhu, FX; He, FC
      Progress in study of structure-function relationship and protein engineering of plasminogen activators

      CHINESE SCIENCE BULLETIN
    24. Wu, WJ; Yamaura, T; Murakami, K; Ogasawara, M; Hayashi, K; Murata, J; Saiki, I
      Involvement of TNF-alpha in enhancement of invasion and metastasis of colon 26-L5 carcinoma cells in mice by social isolation stress

      ONCOLOGY RESEARCH
    25. Murakami, K; Yamaura, T; Suda, K; Ohie, S; Shibata, J; Toko, T; Yamada, Y; Saiki, I
      TAC-101 (4-[3,5-bis(trimethylsilyl)benzamido]benzoic acid) inhibits spontaneous mediastinal lymph node metastasis produced by orthotopic implantationof Lewis lung carcinoma

      JAPANESE JOURNAL OF CANCER RESEARCH
    26. Ueshima, S; Matsumoto, H; Izaki, S; Mitsui, Y; Fukao, H; Okada, K; Matsuo, O
      Co-localization of urokinase and its receptor on established human umbilical vein endothelial cell

      CELL STRUCTURE AND FUNCTION
    27. Zeitler, P; Schuster, V
      Plasma values for u-PA in children

      EUROPEAN JOURNAL OF PEDIATRICS
    28. Seddighzadeh, M; Zhou, JN; Kronenwett, U; Shoshan, MC; Auer, G; Sten-Linder, M; Wiman, B; Linder, S
      ERK signalling in metastatic human MDA-MB-231 breast carcinoma cells is adapted to obtain high urokinase expression and rapid cell proliferation

      CLINICAL & EXPERIMENTAL METASTASIS
    29. Booyse, FM; Aikens, ML; Grenett, HE
      Endothelial cell fibrinolysis: Transcriptional regulation of fibrinolytic protein gene expression (t-PA, n-PA, and PAI-1) by low alcohol

      ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
    30. Fareed, J; Hoppensteadt, DA; Jeske, WP; Ahmad, S; Bick, RL
      Acquired defects of fibrinolysis associated with thrombosis

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    31. Pathak, PN; Veeraraghavan, R; Ruikar, PB; Manchanda, VK
      Solvent extraction studies on Th(IV), Pa(V) and U(VI) from nitric acid medium using di-2-ethyl hexyl isobutyramide (D2EHIBA)

      RADIOCHIMICA ACTA
    32. Ghiso, JAA; Alonso, DF; Farias, EF; Gomez, DE; Joffe, EBD
      Deregulation of the signaling pathways controlling urokinase production - Its relationship with the invasive phenotype

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    33. Scherrer, A; Wohlwend, A; Kruithof, EKO; Vassalli, JD; Sappino, AP
      Plasminogen activation in human acute leukaemias

      BRITISH JOURNAL OF HAEMATOLOGY
    34. Ahn, MY; Zhang, ZG; Tsang, W; Chopp, M
      Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice

      BRAIN RESEARCH
    35. Ahn, MY; Zhang, ZG; Zhang, L; Chopp, M
      The effect of age on expression of endogenous plasminogen activators afterfocal cerebral ischemia in mice

      BRAIN RESEARCH
    36. Casslen, B; Sandberg, T; Gustavsson, B
      Progesterone induced TGF beta, stimulates stromal cell release of u-PA : PAI-1 complex, a paracrine signal for capillary endothelial cell migration; a novel mechanism in endometrial angiogenesis

      10TH WORLD CONGRESS ON HUMAN REPRODUCTION
    37. MAY AE; KANSE SM; CHAVAKIS T; PREISSNER KT
      MOLECULAR-INTERACTIONS BETWEEN THE UROKINASE RECEPTOR AND INTEGRINS IN THE VASCULATURE

      FIBRINOLYSIS & PROTEOLYSIS
    38. CASSLEN B; GUSTAVSSON B; ANGELIN B; GAFVELS M
      DEGRADATION OF UROKINASE PLASMINOGEN-ACTIVATOR (UPA) IN ENDOMETRIAL STROMAL CELLS REQUIRES BOTH THE UPA RECEPTOR AND THE LOW-DENSITY-LIPOPROTEIN RECEPTOR-RELATED PROTEIN ALPHA-2-MACROGLOBULIN RECEPTOR

      Molecular human reproduction (Print)
    39. SWIERCZ R; WOLFE JD; ZAHER A; JANKUN J
      EXPRESSION OF THE PLASMINOGEN ACTIVATION SYSTEM IN KIDNEY CANCER CORRELATES WITH ITS AGGRESSIVE PHENOTYPE

      Clinical cancer research
    40. SWIERCZ R; WOLFE JD; ZAHER A; JANKUN J
      EXPRESSION OF THE PLASMINOGEN ACTIVATION SYSTEM IN KIDNEY CANCER CORRELATES WITH ITS AGGRESSIVE PHENOTYPE

      Clinical cancer research
    41. ISHIKAWA H; SATOH H; KAMMA H; NAITO T; OHTSUKA M; OGATA T; HASEGAWA S
      THE EFFECT OF SN-38 ON CELL-PROLIFERATION AND ON PRODUCTION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR IN HUMAN LUNG-CANCER CELL-LINES

      Cancer research, therapy & control
    42. KIM SJ; SHIBA E; TSUKAMOTO F; IZUKURA M; TAGUCHI T; YONEDA K; TANJI Y; KIMOTO Y; TAKAI S
      THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IS A NOVEL PROGNOSTIC FACTOR IN DUKES-B AND DUKES-C COLORECTAL-CANCER

      Oncology Reports
    43. SAKUKAWA R; MURAKAMI K; IKEDA T; YAMADA Y; SAIKI I
      EFFECT OF 4-[3,5-BIS(TRIMETHYLSILYL)BENZAMIDO] BENZOIC-ACID (TAC-101)ON THE LIVER METASTASIS OF COLON 26-L5 CARCINOMA-CELLS

      Oncology research
    44. BERNEY CR; YANG JL; FISHER RJ; RUSSELL PJ; CROWE PJ
      CORRELATES OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN COLORECTAL-CANCER - POSITIVE RELATIONSHIP WITH NM23 AND C-ERBB-2 PROTEIN EXPRESSION

      Oncology research
    45. DEPIX MS; MARTINEZ J; SANTIBANEZ F; ROVIROSA J; SANMARTIN AS; MACCIONI RB
      THE COMPOUND 14-KETO-STYPODIOL DIACETATE FROM THE ALGAE STYPOPODIUM FLABELLIFORME INHIBITS MICROTUBULES AND CELL-PROLIFERATION IN DU-145 HUMAN PROSTATIC CELLS

      Molecular and cellular biochemistry
    46. LEE MJ; LEE OH; YOON SH; LEE SK; CHUNG MH; PARK YI; SUNG CK; CHOI JS; KIM KW
      IN-VITRO ANGIOGENIC ACTIVITY OF ALOE-VERA GEL ON CALF PULMONARY-ARTERY ENDOTHELIAL (CPAE) CELLS

      Archives of pharmacal research
    47. HARBECK N; DETTMAR P; THOMSSEN C; HENSELMANN B; KUHN W; ULM K; JANICKE F; HOFLER H; GRAEFF H; SCHMITT M
      PROGNOSTIC IMPACT OF TUMOR BIOLOGICAL FACTORS ON SURVIVAL IN NODE-NEGATIVE BREAST-CANCER

      Anticancer research
    48. BERNEY CR; YANG JL; FISHER RJ; RUSSELL PJ; CROWE PJ
      VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION IS REDUCED IN LIVER METASTASIS FROM COLORECTAL-CANCER AND CORRELATES WITH UROKINASE-TYPE PLASMINOGEN-ACTIVATOR

      Anticancer research
    49. HATANE T; YOSHIDA E; KAWANO J; SUGIKI M; ONITSUKA T; MARUYAMA M
      PROSTAGLANDIN I-2 ANALOG ENHANCES THE EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND WOUND-HEALING IN CULTURED HUMAN FIBROBLAST

      Biochimica et biophysica acta. Molecular cell research
    50. Astedt, B; Lindoff, C; Lecander, I
      Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy

      SEMINARS IN THROMBOSIS AND HEMOSTASIS
    51. MAALOE S
      EXTRACTION OF PRIMARY ABYSSAL THOLEIITE FROM A STRATIFIED PLUME

      The Journal of geology
    52. BRUSE C; BERGQVIST A; CARLSTROM K; FIANUJONASSON A; LECANDER I; ASTEDT B
      FIBRINOLYTIC FACTORS IN ENDOMETRIOTIC TISSUE, ENDOMETRIUM, PERITONEAL-FLUID, AND PLASMA FROM WOMEN WITH ENDOMETRIOSIS AND IN ENDOMETRIUM AND PERITONEAL-FLUID FROM HEALTHY WOMEN

      Fertility and sterility
    53. VANORMAN JA; GROVE TL; SHIMIZU N
      URANIUM AND THORIUM DIFFUSION IN DIOPSIDE

      Earth and planetary science letters
    54. Cejkova, J
      The appearance and possible role of plasminogen activator of urokinase type (u-PA) activity in the cornea related to soft contact lens wear in rabbits

      DOCUMENTA OPHTHALMOLOGICA
    55. MCWILLIAM N; ROBBIE L; BOOTH N; BENNETT B
      PLASMINOGEN-ACTIVATOR IN ACUTE MYELOID LEUKEMIC MARROWS - U-PA IN CONTRAST TO T-PA IN NORMAL MARROW

      British Journal of Haematology
    56. SANDBERG T; CASSLEN B; GUSTAVSSON B; BENRAAD TJ
      HUMAN ENDOTHELIAL-CELL MIGRATION IS STIMULATED BY UROKINASE PLASMINOGEN ACTIVATOR-PLASMINOGEN ACTIVATOR INHIBITOR-1 COMPLEX RELEASED FROM ENDOMETRIAL STROMAL CELLS STIMULATED WITH TRANSFORMING-GROWTH-FACTOR BETA-1 - POSSIBLE MECHANISM FOR PARACRINE STIMULATION OF ENDOMETRIAL ANGIOGENESIS

      Biology of reproduction
    57. CASSLEN B; SANDBERG T; GUSTAVSSON B; WILLEN R; NILBERT M
      TRANSFORMING-GROWTH-FACTOR BETA-1 IN THE HUMAN ENDOMETRIUM - CYCLIC VARIATION, INCREASED EXPRESSION BY ESTRADIOL AND PROGESTERONE, AND REGULATION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1

      Biology of reproduction
    58. VANDENBURG PJM; HOSPERS JEH; VANVLIET M; MOSTERD WL; BOUMA BN; HUISVELD IA
      EFFECT OF ENDURANCE TRAINING AND SEASONAL FLUCTUATION ON COAGULATION AND FIBRINOLYSIS IN YOUNG SEDENTARY MEN

      Journal of applied physiology
    59. KANSE SM; BENZAKOUR O; KANTHOU C; KOST C; LIJNEN HR; PREISSNER KT
      INDUCTION OF VASCULAR SMC PROLIFERATION BY UROKINASE INDICATES A NOVEL MECHANISM OF ACTION IN VASOPROLIFERATIVE DISORDERS

      Arteriosclerosis, thrombosis, and vascular biology
    60. WOLLENBERG B; JAN NV; JUND R; CHAUBAL S; UNTCH M
      UROKINASE-TYPE PLASMINOGEN-ACTIVATOR AND ITS INHIBITOR PLASMINOGEN-ACTIVATOR INHIBITOR-1 - NEW FUNCTIONAL RISK-FACTORS IN HEAD AND NECK SQUAMOUS-CELL CANCER

      Oncology Reports
    61. TAKAISHI T; UESHIMA S; MATSUO O
      NEW ASPECTS OF FIBRINOLYTIC PROTEINS IN BRAIN-DEVELOPMENT

      Cell structure and function
    62. GREWE A; ANDRIAMONJE S; BOCKSTIEGEL C; BROHM T; CLERC HG; CZAJKOWSKI S; HANELT E; HEINZ A; ITKIS MG; DEJONG M; JUNGHANS A; PRAVIKOFF MS; SCHMIDT KH; SCHWAB W; STEINHAUSER S; SUMMERER K; VOSS B
      FISSION-BARRIERS FROM ELECTROMAGNETIC FISSION OF 430-CENTER-DOT-A MEVRADIOACTIVE ION-BEAMS

      Nuclear physics. A
    63. PREISSNER KT; MAY AE; WOHN KD; GERMER M; KANSE SM
      MOLECULAR CROSSTALK BETWEEN ADHESION RECEPTORS AND PROTEOLYTIC CASCADES IN VASCULAR REMODELING

      Thrombosis and haemostasis
    64. NOWAKGOTTL U; VIELHABER H; GROHMANN J; SCHNEPPENHEIM R; KOCH HG
      ARGININE(506) TO GLUTAMIN MUTATION IN THE FACTOR-V GENE IN INFANCY AND CHILDHOOD - EVIDENCE OF FIBRINOLYTIC IMPAIRMENT

      European journal of pediatrics
    65. ZHANG WJ; WOJTA J; BINDER BR
      EFFECT OF NOTOGINSENOSIDE R1 ON THE SYNTHESIS OF COMPONENTS OF THE FIBRINOLYTIC SYSTEM IN CULTURED SMOOTH-MUSCLE CELLS OF HUMAN PULMONARY-ARTERY

      Cellular and molecular biology
    66. HERBERT JM; BONO F; LAMARCHE I; CARMELIET P
      THE INHIBITORY EFFECT OF HEPARIN FOR VASCULAR SMOOTH-MUSCLE CELL-PROLIFERATION OR MIGRATION IS NOT MEDIATED BY U-PA AND T-PA

      Thrombosis research
    67. UMEDA T; EGUCHI Y; OKINO K; KODAMA M; HATTORI T
      CELLULAR-LOCALIZATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR, ITS INHIBITORS, AND THEIR MESSENGER-RNAS IN BREAST-CANCER TISSUES

      Journal of pathology
    68. FRANCO P; IACCARINO C; CHIARADONNA F; BRANDAZZA A; IAVARONE C; MASTRONICOLA MR; NOLLI ML; STOPPELLI MP
      PHOSPHORYLATION OF HUMAN PROUROKINASE ON SER(138 303) IMPAIRS ITS RECEPTOR-DEPENDENT ABILITY TO PROMOTE MYELOMONOCYTIC ADHERENCE AND MOTILITY/

      The Journal of cell biology
    69. HERBERT JM; CARMELIET P
      INVOLVEMENT OF U-PA IN THE ANTI-APOPTOTIC ACTIVITY OF TGF-BETA FOR VASCULAR SMOOTH-MUSCLE CELLS

      FEBS letters
    70. ELLIOTT T
      FRACTIONATION OF U AND TH DURING MANTLE MELTING - A REPRISE

      Chemical geology
    71. HACKEL C; CZERNIAK B; AYALA AG; RADIG K; ROESSNER A
      EXPRESSION OF PLASMINOGEN ACTIVATORS AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN DEDIFFERENTIATED CHONDROSARCOMA

      Cancer
    72. BENNETT B; CROLL AM; ROBBIE LA; HERRIOT R
      TUMOR-CELL U-PA AS A CAUSE OF FIBRINOLYTIC BLEEDING IN METASTATIC DISEASE

      British Journal of Haematology
    73. GIBSON PR; ROSELLA O
      ABNORMALITIES OF THE UROKINASE SYSTEM IN COLONIC CRYPT CELLS FROM PATIENTS WITH ULCERATIVE-COLITIS

      Inflammatory bowel diseases
    74. MUKHERJEE M; SEMBHI K; KAKKAR VV
      INTERFERENCE OF AN ACTIVITY ASSAY OF TISSUE-TYPE PLASMINOGEN-ACTIVATOR IN HUMAN PLASMA BY ENDOGENOUS FACTORS

      Blood coagulation & fibrinolysis
    75. NORDENGREN J; CASSLEN B; LECANDER I
      PLASMINOGEN-ACTIVATOR INHIBITOR-2 IN MENSTRUAL ENDOMETRIUM AND IN PRIMARY CULTURES OF ENDOMETRIAL CELLS

      Fibrinolysis
    76. KLUFT C; MEIJER P
      UPDATE 1996 - BLOOD COLLECTION AND HANDLING PROCEDURES FOR ASSESSMENTOF PLASMINOGEN ACTIVATORS AND INHIBITORS (LEIDEN FIBRINOLYSIS WORKSHOP)

      Fibrinolysis
    77. MATSUMOTO H; UESHIMA S; FUKAO H; MITSUI Y; MATSUO O
      EFFECTS OF LIPOPOLYSACCHARIDE ON THE EXPRESSION OF FIBRINOLYTIC FACTORS IN AN ESTABLISHED CELL-LINE FROM HUMAN ENDOTHELIAL-CELLS

      Life sciences
    78. YEBRA M; PARRY GCN; STROMBLAD S; MACKMAN N; ROSENBERG S; MUELLER BM; CHERESH DA
      REQUIREMENT OF RECEPTOR-BOUND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR FOR INTEGRIN ALPHA-V-BETA-5-DIRECTED CELL-MIGRATION

      The Journal of biological chemistry
    79. HOFMANN R; LEHMER A; BURESCH M; HARTUNG R; ULM K
      CLINICAL RELEVANCE OF UROKINASE PLASMINOGEN-ACTIVATOR, ITS RECEPTOR, AND ITS INHIBITOR IN PATIENTS WITH RENAL-CELL CARCINOMA

      Cancer
    80. HIGAZI AAR; UPSON RH; COHEN RL; MANUPPELLO J; BOGNACKI J; HENKIN J; MCCRAE KR; KOUNNAS MZ; STRICKLAND DK; PREISSNER KT; LAWLER J; CINES DB
      INTERACTION OF SINGLE-CHAIN UROKINASE WITH ITS RECEPTOR INDUCES THE APPEARANCE AND DISAPPEARANCE OF BINDING EPITOPES WITHIN THE RESULTANT COMPLEX FOR OTHER CELL-SURFACE PROTEINS

      Blood
    81. ITAYA T; SUZUKI K; TAKAGI I; MOTAI H; BABA S
      RELATIONSHIP BETWEEN HEAD AND NECK SQUAMOUS-CELL CARCINOMAS AND FIBRINOLYTIC FACTORS - IMMUNOHISTOLOGICAL STUDY

      Acta oto-laryngologica
    82. ITO Y; TAKEDA T; WAKASUGI E; UMESHITA K; FUKUDA H; MONDEN T; KOBAYASHI T; SHIMANO T; MONDEN M
      EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN VARIOUS HUMAN THYROID TISSUES

      Oncology Reports
    83. MATSUMOTO H; UESHIMA S; FUKAO H; MITSUI Y; MATSUO O
      IDENTIFICATION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTOR IN HUMAN ENDOTHELIAL-CELLS AND ITS MODULATION BY PHORBOL-MYRISTATE ACETATE

      Cell structure and function
    84. NONAKA T; MATSUMOTO H; SHIMADA W; MIYAGI I; OKADA K; FUKAO H; UESHIMA S; KIKUCHI H; TANAKA S; MATSUO O
      EFFECT OF CYCLIC-AMP ON UROKINASE-TYPE PLASMINOGEN-ACTIVATOR RECEPTORAND FIBRINOLYTIC FACTORS IN A HUMAN OSTEOBLAST-LIKE CELL-LINE

      Biochimica et biophysica acta. Molecular cell research
    85. CEJKOVA J; LOJDA Z
      THE APPEARANCE OF ACTIVE PLASMINOGEN-ACTIVATOR OF UROKINASE-TYPE (U-PA) IN THE RABBIT ANTERIOR EYE SEGMENT IRRADIATED BY UVB RAYS - A HISTOCHEMICAL AND BIOCHEMICAL-STUDY

      Acta histochemica
    86. FRIST ST; TAYLOR HA; KIRK KA; GRAMMER JR; LI XN; GRENETT HE; BOOYSE FM
      EXPRESSION OF PAI-1, T-PA AND U-PA IN CULTURED HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS DERIVED FROM RACIAL GROUPS

      Thrombosis research
    87. AKA AK; BARCI V; ARDISSON G; RIGHETTI R; LEDU JF; TRUBERT D
      REINVESTIGATION OF DECAY PROPERTIES OF NUCLEI BELONGING TO THE U-230 SERIES USING CONTINUOUS RADIOCHEMICAL SEPARATIONS

      Radiochimica Acta
    88. BOXMAN ILA; QUAX PHA; LOWIK CWGM; PAPAPOULOS SE; VERHEIJEN J; PONEC M
      DIFFERENTIAL REGULATION OF PLASMINOGEN ACTIVATION IN NORMAL KERATINOCYTES AND SCC-4 CELLS BY FIBROBLASTS

      Journal of investigative dermatology
    89. CHANDLER WL; LEVY WC; STRATTON JR
      THE CIRCULATORY REGULATION OF TPA AND UPA SECRETION, CLEARANCE, AND INHIBITION DURING EXERCISE AND DURING THE INFUSION OF ISOPROTERENOL ANDPHENYLEPHRINE

      Circulation
    90. WADA K; TAKAHASHI H; HANANO M; TATEWAKI W; NIWANO H; SEKI Y; SHIBATA A
      PLASMA UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PATIENTS WITH LEUKEMIAS

      Leukemia & lymphoma
    91. WILL C; WILHELM O; HOHL S; MOBUS V; WEIDLE U; KREIENBERG R; JANICKE F; SCHMITT M; GRAEFF H
      EXPRESSION OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR (UPA) AND ITS RECEPTOR (UPAR) IN HUMAN OVARIAN-CANCER CELLS AND IN-VITRO INVASION CAPACITY

      International journal of oncology
    92. SATO S; HIGASHI T; OUGUCHI S; HINO N; TSUJI T
      ELEVATED UROKINASE-TYPE PLASMINOGEN-ACTIVATOR PLASMA-LEVELS ARE ASSOCIATED WITH DETERIORATION OF LIVER-FUNCTION BUT NOT WITH HEPATOCELLULAR-CARCINOMA

      Journal of gastroenterology
    93. WILHELM O; REUNING U; JANICKE F; SCHMITT M; GRAEFF H
      THE ROLE OF PROTEASES IN TUMOR INVASION AND METASTASIS - PROGNOSTIC IMPACT AND THERAPEUTIC CHALLENGE

      Onkologie
    94. QUAX PHA; BOXMAN LA; VANKESTEREN CAM; VERHEIJEN JH; PONEC M
      PLASMINOGEN ACTIVATORS ARE INVOLVED IN KERATINOCYTE AND FIBROBLAST MIGRATION IN WOUNDED CULTURES IN-VITRO

      Fibrinolysis
    95. KOOK YH; ADAMSKI J; ZELENT A; OSSOWSKI L
      THE EFFECT OF ANTISENSE INHIBITION OF UROKINASE RECEPTOR IN HUMAN SQUAMOUS-CELL CARCINOMA ON MALIGNANCY

      EMBO journal
    96. MARTINEZ J; SANTIBANEZ JF
      SURFACE-ASSOCIATED PLASMINOGEN ACTIVATION IN LEUKEMIC-CELLS - INTERACTION WITH EXTRACELLULAR-MATRIX

      European journal of cell biology
    97. OKA K; TSUDA H; SAKAMOTO S; GO Y; TOMONAGA M
      PLASMINOGEN-ACTIVATOR AND HEMORRHAGE IN BRAIN-TUMORS

      Journal of neuro-oncology
    98. TAKADA Y; URANO T; TAKADA A
      EFFECTS OF HEPARIN SULFATE ANALOG OR OTHER SULFATED POLYSACCHARIDES ON THE ACTIVATION OF PLASMINOGEN BY T-PA OR U-PA

      Thrombosis research
    99. NAGAYAMA M; SATO A; HAYAKAWA H; URANO T; TAKADA Y; TAKADA A
      PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS IN NONSMALL CELL LUNG-CANCER - LOW CONTENT OF TYPE-2 PLASMINOGEN-ACTIVATOR INHIBITOR ASSOCIATEDWITH TUMOR DISSEMINATION

      Cancer
    100. VANDEWERF F; LIJNEN HR; COLLEN D
      CORONARY THROMBOLYSIS WITH K(1)K(2)P(U), A CHIMERIC TISSUE-TYPE AND UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - A FEASIBILITY STUDY IN 6 PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION

      Coronary artery disease


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 27/01/21 alle ore 18:18:32